Cytosorbents (CTSO) Tops Q3 EPS by 1c, Misses on Revenue

Cytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $10.4 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• TPU-As-A-Service could boost Google’s 2028 profit by over 15%: Barclays
• Increasing unusual call volume: ANGX TSLT UNM SBAC AVTR CBRG RNG THC MAT LQD
• This stock is described as a "deep value jewel"